MétaCan
Menu
Back to cohort
Record W4414011186 · doi:10.1158/1535-7163.mct-25-0428

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort

2025· article· en· W4414011186 on OpenAlexaff
Filemon S. Dela Cruz, Elizabeth Stewart, Didier Surdez, Jessica D. Daley, Alice Soragni, Eleni M. Tomazou, Jaime Alvarez-Perez, Tamar Y. Feinberg, James F. Amatruda, Shireen Ganapathi, Joyce E. Ohm, Christine M. Heske, Sarah Cohen‐Gogo, Dusan Pesic, Joshua O. Nash, Adam Shlien, Elizabeth A. Roundhill, Susan A. Burchill, Brian D. Crompton, Elizabeth R. Lawlor, David M. Loeb, Olivier Delattre, Jaume Mora, Katia Scotlandi, Damon R. Reed, Patrick J. Grohar, Thomas G. P. Grünewald, Heinrich Kovar, Kelly M. Bailey

Bibliographic record

VenueMolecular Cancer Therapeutics · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsSickKids FoundationHospital for Sick Children
FundersNational Institutes of HealthAlan B. Slifka FoundationNational Cancer InstituteSarcoma UK
KeywordsSarcomaBiologyPreclinical testingEwing's sarcomaPreclinical researchCancer researchMedicineComputational biologyVirologyBioinformaticsPathology

Abstract

fetched live from OpenAlex

Ewing sarcoma is an aggressive bone and soft-tissue cancer affecting adolescents and young adults. In vitro and in vivo models of Ewing sarcoma have been instrumental in advancing our understanding of Ewing sarcoma biology and essential in evaluating potential therapies, particularly for metastatic or relapsed disease for which effective treatment options remain limited. Through an international collaborative effort between the Children's Oncology Group Bone Tumor Committee and the Euro Ewing Consortium, we review the current landscape of preclinical modeling used in Ewing sarcoma research encompassing both in vitro (cell lines and tumor organoids) and in vivo (mouse and nonmammalian xenografts) model systems. We discuss factors that can influence experimental results, provide testing considerations for both in vitro and in vivo studies, and descriptions of existing preclinical data repositories. We highlight current needs in Ewing sarcoma modeling and the importance of enhanced international cooperative research and patient advocacy efforts which will be critical in expanding our resources of biologically relevant Ewing sarcoma models to enable translation of preclinical findings into effective therapeutic strategies for patients with Ewing sarcoma.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.107
metaresearch head score (Gemma)0.036
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: none
Teacher disagreement score0.107
Threshold uncertainty score0.568

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1070.036
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0060.005
Science and technology studies0.0010.005
Scholarly communication0.0100.013
Open science0.0040.009
Research integrity0.0030.009
Insufficient payload (model declined to judge)0.0070.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.363
Teacher spread0.341 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicCancer Genomics and DiagnosticsFrench-language works237,207